Insider Transactions in Q1 2022 at Uni Qure N.V. (QURE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
Robert Gut Director |
SELL
Open market or private sale
|
Direct |
1,602
-4.37%
|
$25,632
$16.7 P/Share
|
|
Feb 28
2022
|
Alexander Edward Kuta Iii Executive VP, Operations |
SELL
Open market or private sale
|
Direct |
3,405
-3.45%
|
$54,480
$16.72 P/Share
|
|
Feb 28
2022
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,075
-3.69%
|
$65,200
$16.8 P/Share
|
|
Feb 28
2022
|
Ricardo Dolmetsch President, R&D |
SELL
Open market or private sale
|
Direct |
1,484
-1.2%
|
$23,744
$16.68 P/Share
|
|
Feb 28
2022
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
10,195
-2.75%
|
$163,120
$16.7 P/Share
|
|
Feb 28
2022
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
596
-7.55%
|
$9,536
$16.87 P/Share
|
|
Feb 28
2022
|
Madhavan Balachandran Director |
SELL
Open market or private sale
|
Direct |
602
-5.24%
|
$9,632
$16.7 P/Share
|
|
Feb 28
2022
|
David D. Meek Director |
SELL
Open market or private sale
|
Direct |
602
-7.54%
|
$9,632
$16.7 P/Share
|
|
Feb 28
2022
|
Jeremy P. Springhorn Director |
SELL
Open market or private sale
|
Direct |
602
-5.24%
|
$9,632
$16.7 P/Share
|
|
Feb 28
2022
|
Jack Kaye Director |
SELL
Open market or private sale
|
Direct |
600
-3.06%
|
$9,600
$16.76 P/Share
|
|
Feb 28
2022
|
Leonard E Post Director |
SELL
Open market or private sale
|
Direct |
795
-20.3%
|
$12,720
$16.64 P/Share
|
|
Feb 24
2022
|
Robert Gut Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+4.01%
|
-
|
|
Feb 24
2022
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,073
+25.23%
|
-
|
|
Feb 24
2022
|
Alexander Edward Kuta Iii Executive VP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
34,904
+26.14%
|
-
|
|
Feb 24
2022
|
Christian Klemt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,630
+28.32%
|
-
|
|
Feb 24
2022
|
Pierre Caloz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,086
+33.97%
|
-
|
|
Feb 24
2022
|
Ricardo Dolmetsch President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
54,683
+30.64%
|
-
|
|
Feb 24
2022
|
Rachelle Suzanne Jacques Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+50.0%
|
-
|
|
Feb 24
2022
|
Paula Soteropoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+16.26%
|
-
|
|
Feb 24
2022
|
Madhavan Balachandran Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+11.79%
|
-
|
|
Feb 24
2022
|
David D. Meek Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+16.12%
|
-
|
|
Feb 24
2022
|
Jeremy P. Springhorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+11.79%
|
-
|
|
Feb 24
2022
|
Jack Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+7.26%
|
-
|
|
Feb 24
2022
|
Leonard E Post Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+28.15%
|
-
|
|
Jan 26
2022
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
10,901
-4.25%
|
$196,218
$18.1 P/Share
|
|
Jan 26
2022
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,963
-5.6%
|
$71,334
$18.03 P/Share
|
|
Jan 26
2022
|
Alexander Edward Kuta Iii Executive VP, Operations |
SELL
Open market or private sale
|
Direct |
2,945
-4.42%
|
$53,010
$18.02 P/Share
|
|
Jan 26
2022
|
Robert Gut Director |
SELL
Open market or private sale
|
Direct |
2,348
-6.26%
|
$42,264
$18.12 P/Share
|